We are pretty sure that because of the hype, quite a few people now know what HYPOCHLOROUS ACID is. For those who don't...read on to learn more.
Either way we are sure you will agree that it is an exciting product.
We are excited to be a part of the worldwide HOCl movement!
HOCl was first identified over 150 years ago. it was difficult to study since it rapidly deactivated and converted to a simple salty byproduct. Advances in technology have enabled us to manufacture stable and highly potent HOCl through a process called Electro-Chemical Activation (ECA)
HOCl (Hypochlorous Acid), is naturally produced in our bodies by our white blood cells to fight off pathogens. These white blood cells are called neutrophils, they make up approximately 55% of the white blood cells in our bodies.
1(a). A rapidly moving neutrophil can be seen taking up several conidia
Neutrophils phagocytose or "ingest" bacteria. The neutrophil then releases enzymes, which after some processes convert to HOCl.
HOCl is a powerful bactericide. It oxidizes proteins and the thin walls of pathogens are no match! HOCl causes these cells to burst and die. Viruses can't mutate.
Softened Water & Brine (made of salt or potassium) are pumped into the cell.
HOCl (Anolyte) and Potassium OR Sodium Hydroxide (Catholyte) are the result.
BOTH output solutions are useful and harmless to our environment.
Judith Behnsen, Priyanka Narang, Mike Hasenberg, Frank Gunzer, Ursula Bilitewski, Nina Klippel, Manfred Rohde, Matthias Brock, Axel A. Brakhage, Matthias Gunzer, CC BY 2.5 < via Wikimedia Commons
Supporting Studies from Outside of Canada*
Biodecontaminant for Removal PMMA Dental Prostheses
Safe Drinking Water Supply for River Bound Communities in India
Application of electrolysed oxidising water as a sanitiser to extend the shelf-life of seafood products: a review
Application of electrolyzed oxidized water for irrigation in a burn-wound infection
Evaluation of sprayed hypochlorous acid solutions for their virucidal activity against avian influenza virus through in vitro experiments
Evaluation of HOCl-generating anticancer agents by an ultrasensitive dual-mode fluorescent probe